Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health (INTEGRATE-CHW)
Integrating Tailored Medical Nutrition Therapy and Community Health Worker Support to Advance Cardio-Kidney-Metabolic Health
This study tests whether adding CHW support to usual nutrition care helps adults with type 2 diabetes, hypertension, or chronic kidney disease manage their diet and health. At Caridad Center, a free clinic in Palm Beach County, Florida, usual care includes medical nutrition therapy from a registered dietitian and medically tailored groceries. Many patients find it hard to keep up dietary changes because of limited nutrition knowledge, cooking skills, food costs, and cultural fit.
Two hundred adults will be randomly assigned to usual care or usual care plus INTEGRATE-CHW, a 12-week program of six sessions with a trained CHW. In each session the participant selects one or two goals from the dietitian's plan and builds an action plan with the CHW. The dietitian remains responsible for the nutrition plan. The study will compare nutrition self-efficacy, nutrition literacy, diet quality, food security, and clinical measures between groups at baseline and Week 12. It will also evaluate how well the program fits into routine clinic care.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
Dietitian-led MNT and medically tailored food programs improve diet quality and food security during active participation, but these gains often diminish once food delivery or counseling ends. Sustaining improvement requires ongoing behavioral reinforcement and self-management support that help patients adapt nutrition guidance to their cultural and household routines. This trial tests whether CHWs embedded in the dietitian's workflow can provide that reinforcement within routine care at a safety-net clinic.
The intervention is guided by Social Cognitive Theory, the Corbin and Strauss self-management framework, and Lorig and Holman's self-management skills. Self-efficacy serves as the central behavioral mechanism of change, operationalized through confidence-based goal setting, problem solving, and action planning. Enhanced self-efficacy is expected to improve adherence to dietary goals and, in turn, clinical cardio-kidney-metabolic indicators.
Aim 1 will determine the effect of INTEGRATE-CHW on behavioral outcomes. Aim 2 will examine preliminary effects on clinical outcomes. Aim 3 will evaluate implementation using mixed methods guided by RE-AIM and Proctor's framework, including semi-structured interviews with approximately 15 intervention participants and 5 staff (CHWs, registered dietitians, and clinic leads) exploring satisfaction, perceived burden, and workflow fit.
Analyses follow the intent-to-treat principle with two-sided tests (α = 0.05) and Benjamini-Hochberg false-discovery control. Between-group differences at Week 12 are estimated with analysis of covariance adjusting for baseline values. Behavioral models adjust for age, sex, language, baseline food insecurity, and CKD status. Clinical models adjust for age, sex, CKM profile, and medication classes (SGLT2 inhibitor, GLP-1 receptor agonist, ACE inhibitor/ARB, and statin use). Linear mixed-effects models are used for sensitivity analyses. Exploratory analyses test effect modification by baseline food insecurity, nutrition literacy level, and dominant CKM condition, and test whether changes in self-efficacy, literacy, or diet quality mediate changes in clinical indicators. A total of 200 participants (100 per arm) provides at least 80% power (α = 0.05) to detect a small-to-moderate effect (Cohen's d ≈ 0.35).
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Jordan Program coordinator
- 電話番号:305-348-4720
- メール:joquinta@fiu.edu
研究場所
-
-
Florida
-
Boynton Beach、Florida、アメリカ、33472
- Caridad Center, Inc.
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Adults aged 18 years or older receiving care at Caridad Center
- Documented diagnosis of type 2 diabetes (HbA1c ≥ 6.5%), hypertension (systolic blood pressure ≥ 130 mmHg), or chronic kidney disease Stages 1-4 (eGFR 15-59 mL/min/1.73 m² regardless of albuminuria, or eGFR ≥ 15 mL/min/1.73 m² with albuminuria ≥ 30 mg/g)
- Eligible for medical nutrition therapy and medically tailored groceries through -Caridad Center
- Able to provide informed consent in English or Spanish
Exclusion Criteria:
- Dialysis or advanced kidney failure (CKD Stage 5; eGFR < 15 mL/min/1.73 m²)
- Pregnancy
- Cognitive impairment precluding participation
- Plans to relocate during the 12-week intervention
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:ヘルスサービス研究
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:INTEGRATE-CHW
Usual care plus a 12-week CHW-delivered, nutrition-focused self-management support program: six sessions of approximately 60 minutes at Weeks 1, 3, 5, 7, 9, and 11, delivered in person or virtually by participant preference, and a Week 12 wrap-up aligned with the routine dietitian visit and laboratory review. |
Trained CHWs deliver culturally tailored sessions using FlipChart visuals, pictorial goal cards, and recipe swaps. The curriculum covers diet and CKM links and home blood pressure and glucose monitoring (Session 1), diabetes (Session 2), hypertension (Session 3), CKD (Session 4), cardiometabolic integration (Session 5), and maintenance (Session 6). Participants select one to two goals from their dietitian's plan and build confidence-rated action plans. CHWs reinforce, but do not modify, dietitian guidance. Between sessions, CHWs provide reminder and follow-up contact by telephone or text message. Participants enter home blood pressure and glucose readings and goals into REDCap directly or with CHW assistance. |
|
アクティブコンパレータ:Usual Care
Caridad Center standard care: individualized medical nutrition therapy from a registered dietitian approximately every three months and medically tailored groceries or meal boxes biweekly for 12 weeks. |
Individualized medical nutrition therapy from a registered dietitian following the Academy of Nutrition and Dietetics' Nutrition Care Process, plus biweekly medically tailored groceries or meal boxes for 12 weeks. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change From Baseline in Nutrition Self-Efficacy Scale Score at Week 12
時間枠:Baseline and Week 12
|
5-item Nutrition Self-Efficacy Scale, which measures confidence in maintaining healthy eating behaviors despite common barriers. Interviewer-administered in English or Spanish. |
Baseline and Week 12
|
|
Change From Baseline in Short Food Literacy Questionnaire (SFLQ) Score at Week 12
時間枠:Baseline and Week 12
|
12-item Short Food Literacy Questionnaire (SFLQ), which evaluates the ability to interpret nutrition information, read labels, and make balanced food choices. Interviewer-administered in English or Spanish. |
Baseline and Week 12
|
|
Change From Baseline in Healthy Eating Index-2020 (HEI-2020) Total Score at Week 12
時間枠:Baseline and Week 12
|
Healthy Eating Index-2020 (HEI-2020) total score, derived from two 24-hour dietary recalls. |
Baseline and Week 12
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change From Baseline in USDA Six-Item Food Security Module Score at Week 12
時間枠:Baseline and Week 12
|
USDA six-item food security module. |
Baseline and Week 12
|
|
Change From Baseline in HbA1c (%) at Week 12
時間枠:Baseline and Week 12
|
Glycated hemoglobin (%), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Systolic Blood Pressure (mmHg) at Week 12
時間枠:Baseline and Week 12
|
Systolic blood pressure (mmHg), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Diastolic Blood Pressure (mmHg) at Week 12
時間枠:Baseline and Week 12
|
Diastolic blood pressure (mmHg), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Body Mass Index (kg/m²) at Week 12
時間枠:Baseline and Week 12
|
Body mass index (kg/m²), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Lipid Profile at Week 12
時間枠:Baseline and Week 12
|
Lipid profile, extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in eGFR (mL/min/1.73 m²) at Week 12
時間枠:Baseline and Week 12
|
eGFR (mL/min/1.73 m²), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Urinary Albumin-to-Creatinine Ratio (mg/g) at Week 12
時間枠:Baseline and Week 12
|
uACR (mg/g), extracted from the electronic medical record; log-transformed and reported as ratios of geometric means. |
Baseline and Week 12
|
その他の成果指標
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Feasibility: Proportion of Eligible Patients Who Enroll and Complete Follow-up
時間枠:Enrollment through Week 12 follow-up
|
Proportion of eligible patients who enroll and complete follow-up. |
Enrollment through Week 12 follow-up
|
|
Reach: Demographic Comparability of Enrolled Participants With the Clinic's CKM Population
時間枠:Enrollment period
|
Demographic comparability between enrolled participants and the clinic's CKM population. |
Enrollment period
|
|
Fidelity: Percentage of CHW Sessions Meeting All Required Elements
時間枠:Weeks 1-12
|
Percentage of CHW sessions meeting all required elements, assessed through CHW session checklists, direct observation, and periodic audio review. |
Weeks 1-12
|
|
Acceptability: Theoretical Framework of Acceptability (TFA) Survey Score
時間枠:Week 12
|
Theoretical Framework of Acceptability (TFA) survey completed by intervention participants. |
Week 12
|
|
Adoption: Proportion of RDs, CHWs, and Food Partners Delivering the Program as Intended
時間枠:Up to 21 months (intervention delivery period)
|
Proportion of participating registered dietitians, CHWs, and food partners delivering the program as intended. |
Up to 21 months (intervention delivery period)
|
|
Incremental Cost per Participant (US Dollars)
時間枠:12 weeks
|
Estimated from staff time, session duration, and supply costs, with cost per unit outcome. |
12 weeks
|
協力者と研究者
協力者
協力者
捜査官
捜査官
- 主任研究者:Janet Diaz Martinez、Florida International University
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- IRB-26-0430
- 2027-68015-47755 (その他の助成金/資金番号:USDA National Institute of Food and Agriculture)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Following publication of primary findings, de-identified datasets, data dictionaries, and codebooks will be made available through FIU's secure repository. Shared files will exclude personally identifiable information and contain only derived variables.
IPD 共有時間枠
Following publication of primary findings; data will remain available for at least five years after project completion or publication of final results, whichever occurs later.
IPD 共有アクセス基準
De-identified datasets, data dictionaries, codebooks, and analytic code will be available to researchers through FIU's institutional repository and, where applicable, the USDA Ag Data Commons, under FIU's Open Data Policy for research and educational re-use with attribution. Shared files will exclude personally identifiable information and contain only derived variables. Requests for restricted materials, such as qualitative transcripts, will require a data-use agreement and ethics approval.
IPD 共有サポート情報タイプ
- ANALYTIC_CODE
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。